These final results, together with a previous report displaying that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 assist the principle of targeting ACKR3 as a novel approach to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-similar Issues. We independently research, evaluation, https://josephe051siz6.bloggazza.com/profile